Jefferies Comments on Biogen (BIIB) Following Further BG12 Phase 3 DEFINE Analysis; Remains Bullish on Prospects in MS Use
Go back to Jefferies Comments on Biogen (BIIB) Following Further BG12 Phase 3 DEFINE Analysis; Remains Bullish on Prospects in MS Use| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 216.78 +2.43 (1.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $214.35 | 52 Week High | $333.65 | |||
| Open | $217.76 | 52 Week Low | $223.02 | |||
| Day High | $219.12 | P/E | 27.76 | |||
| Day Low | $215.00 | EPS | $7.81 | |||
| Volume | 722,348 | |||||
